James Atkins to Receptors, Serotonin, 5-HT3
This is a "connection" page, showing publications James Atkins has written about Receptors, Serotonin, 5-HT3.
Connection Strength
0.014
-
Hickok JT, Roscoe JA, Morrow GR, King DK, Atkins JN, Fitch TR. Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treated in the community. Cancer. 2003 Jun 01; 97(11):2880-6.
Score: 0.014